We are live on ! Find out more
RCI

Ridgeback Capital Investments Portfolio holdings

AUM $560K
This Fund
S&P 500
This Quarter Est. Return
+29.21%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$184M
AUM Growth
Cap. Flow
+$178M
Cap. Flow %
97.07%
Top 10 Hldgs %
100%
Holding
3
New
3
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCYC
1
Bicycle Therapeutics
BCYC
$280M
$132M 71.77%
+2,164,801
New +$119M
AFMD
2
DELISTED
Affimed
AFMD
$42.6M 23.22%
+772,211
New +$47.7M
FSTX
3
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$9.21M 5.02%
+1,834,360
New +$11.1M

Similar funds

Ridgeback Capital Investments's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Ridgeback Capital Investments, which disclosed 3 positions worth $184M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is Bicycle Therapeutics: 2,164,801 shares worth $132M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Ridgeback Capital Investments's largest Q4 2021 buy was Bicycle Therapeutics: 2,164,801 shares worth $132M.
  • Ridgeback Capital Investments's ten largest holdings make up 100% of its $184M portfolio in Q4 2021.
  • Ridgeback Capital Investments disclosed 3 positions in Q4 2021, its first 13F filing on record.

Based on Ridgeback Capital Investments's 13F filing for Q4 2021, filed 14 Feb 2022.